Lord, Abbett & Co. LLC Verastem, Inc. Transaction History

Lord, Abbett & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.05 - $3.2 $2.79 Million - $4.36 Million	-1,362,287 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$2.54 - $4.07 $44,538 - $71,367	-17,535 Reduced 1.27%	1,362,287 $4.2 Million
Q2 2021 Aug 11, 2021	BUY	$2.57 - $4.85 $3.55 Million - $6.69 Million	1,379,822 New	1,379,822 $5.62 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.